Matches in Wikidata for { <http://www.wikidata.org/entity/Q90767499> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q90767499 description "article scientifique publié en 2019" @default.
- Q90767499 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90767499 description "scientific article published on 17 October 2019" @default.
- Q90767499 description "wetenschappelijk artikel" @default.
- Q90767499 description "наукова стаття, опублікована 17 жовтня 2019" @default.
- Q90767499 name "Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naïve Persons with HIV Infection: a Phase IIB Trial" @default.
- Q90767499 name "Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naïve Persons with HIV Infection: a Phase IIB Trial" @default.
- Q90767499 type Item @default.
- Q90767499 label "Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naïve Persons with HIV Infection: a Phase IIB Trial" @default.
- Q90767499 label "Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naïve Persons with HIV Infection: a Phase IIB Trial" @default.
- Q90767499 prefLabel "Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naïve Persons with HIV Infection: a Phase IIB Trial" @default.
- Q90767499 prefLabel "Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naïve Persons with HIV Infection: a Phase IIB Trial" @default.
- Q90767499 P1433 Q90767499-CFBB66A8-6EC3-4563-9D73-6813B349AF4E @default.
- Q90767499 P1476 Q90767499-02725615-E391-4FF4-80F1-EFD3E6B410E5 @default.
- Q90767499 P2093 Q90767499-2A907A39-BA42-40F0-98DD-48E3A13BB85A @default.
- Q90767499 P2093 Q90767499-655FCE9E-CDC1-4430-9B7F-FC29912798A0 @default.
- Q90767499 P2093 Q90767499-70E0D45F-7120-41B6-9A5E-8F93D45FCC3A @default.
- Q90767499 P2093 Q90767499-8C8094C9-EDBB-41A8-BB86-53B4748EA3FB @default.
- Q90767499 P2093 Q90767499-950DF348-72EB-4A76-8797-FA8790B79CFC @default.
- Q90767499 P2093 Q90767499-9FCE68E3-8465-4853-B1C4-5B7FDABF91EC @default.
- Q90767499 P2093 Q90767499-BF0D853F-8B2D-46FB-AA29-32F7206E3121 @default.
- Q90767499 P2093 Q90767499-E882F5C5-8497-491C-9039-65730CA159F3 @default.
- Q90767499 P2093 Q90767499-F196B8CE-326C-4CAE-BA1E-E80A678A20FB @default.
- Q90767499 P31 Q90767499-BF173724-DD6A-447E-B2F8-EFA7C2E60C41 @default.
- Q90767499 P356 Q90767499-FD75FFD1-1D23-4C89-BA91-9C450EDC8BA2 @default.
- Q90767499 P50 Q90767499-53F4326C-1D94-465B-B143-F873BC35DD89 @default.
- Q90767499 P50 Q90767499-6284866B-E326-4AEF-A8DD-C3591A799634 @default.
- Q90767499 P577 Q90767499-9FC036BD-BBD0-40C8-91CD-015B3168D672 @default.
- Q90767499 P698 Q90767499-9A325FBC-7B57-4F6C-82D0-6BD1BAFFAC34 @default.
- Q90767499 P921 Q90767499-74816D1A-3B13-405B-8B12-0580401A9B4E @default.
- Q90767499 P356 CIZ1027 @default.
- Q90767499 P698 31621838 @default.
- Q90767499 P1433 Q5133764 @default.
- Q90767499 P1476 "Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naïve Persons with HIV Infection: a Phase IIB Trial" @default.
- Q90767499 P2093 "Anandi N Sheth" @default.
- Q90767499 P2093 "Antonina Foster" @default.
- Q90767499 P2093 "Caitlin A Moran" @default.
- Q90767499 P2093 "Cecile D Lahiri" @default.
- Q90767499 P2093 "Ighovwerha Ofotokun" @default.
- Q90767499 P2093 "Jeffrey L Lennox" @default.
- Q90767499 P2093 "Kehmia Titanji" @default.
- Q90767499 P2093 "Laura Ward" @default.
- Q90767499 P2093 "M Neale Weitzmann" @default.
- Q90767499 P31 Q13442814 @default.
- Q90767499 P356 "10.1093/CID/CIZ1027" @default.
- Q90767499 P50 Q40532542 @default.
- Q90767499 P50 Q56871227 @default.
- Q90767499 P577 "2019-10-17T00:00:00Z" @default.
- Q90767499 P698 "31621838" @default.
- Q90767499 P921 Q218507 @default.